S mainly impairs mitochondria by reducing MMP and ATP production, increasing fragmentation and oxidative stress
Nauck MA, Meier JJ (2016) The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions
Important safety note: Because retatrutide is unlicensed in the UK, there is no MHRA-approved Summary of Product Characteristics or monitoring recommendations for routine clinical use, and there is no regulated supply chain
This is where options like AgelessRx tend to stand out, with an approach rooted in education, evidence-based care, and individualized dosing
Protein disulfide isomerase-immunopositive inclusions in patients with amyotrophic lateral sclerosis